P3T® technology is a contrast-injection software that enables technologists to automate personalized contrast dosing at the point of care. P3T is proven to enable a higher percentage of CT Pulmonary Angiography studies of diagnostic quality vs. using a standard protocol across patient populations¹. Unique clinical factors influence each contrast-enhanced CT study. Using P3T, technologists enable injector-based algorithms to tailor each patient’s contrast protocol to account for wide ranges in study variables, including:
- Body Weight
- Study type
- Speed of the scanner* and contrast type being used
|
 |
P3T® software supports a comprehensive suite of products that personalize CT contrast-enhanced imaging. The software automates individualized protocol programming to meet today’s dynamic CT imaging environment. The growing P3T product lines include:
- P3T® PA (Pulmonary Angiography) – CT Angiography of the pulmonary vasculature
- P3T® Cardiac - CT Angiography of the cardiac structures, chambers of the heart, and aorta
- P3T® Abdomen – CT imaging of the liver, pancreas and kidneys
“A little old lady whose heart is not pumping so vigorously anymore will need less contrast than a younger person with a fast cardiac output.”
-U. Joseph Schoepf, MD Associate Professor of Diagnostic Radiology at the Medical University of South Carolina in Radiology Today, February 5, 2008
*P3T® Cardiac and P3T® PA only
¹ Presented at Society of Thoracic Radiology (2008) Poster Session; Christopher R. Deible, MD, PhD. Study supported by MEDRAD.